• No results found

University of Groningen Next generation sequencing guided molecular diagnostic tests in non-small-cell lung cancer Wei, Jiacong

N/A
N/A
Protected

Academic year: 2021

Share "University of Groningen Next generation sequencing guided molecular diagnostic tests in non-small-cell lung cancer Wei, Jiacong"

Copied!
2
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

University of Groningen

Next generation sequencing guided molecular diagnostic tests in non-small-cell lung cancer

Wei, Jiacong

DOI:

10.33612/diss.101317239

IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from it. Please check the document version below.

Document Version

Publisher's PDF, also known as Version of record

Publication date: 2019

Link to publication in University of Groningen/UMCG research database

Citation for published version (APA):

Wei, J. (2019). Next generation sequencing guided molecular diagnostic tests in non-small-cell lung cancer. Rijksuniversiteit Groningen. https://doi.org/10.33612/diss.101317239

Copyright

Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).

Take-down policy

If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim.

Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the number of authors shown on this cover page is limited to 10 maximum.

(2)

Stellingen

Behorende bij het proefschrift

Next Generation Sequencing Guided Molecular

Diagnostic Tests in Lung Cancer

1. Chromosomal translocations affecting the ALK locus do not necessarily lead to altered mRNA and / or protein levels (this thesis).

2. RNA-based method may outperform a DNA based method in detecting multiple types of activating (driver) mutations (this thesis).

3. Epithelial-mesenchymal transition plays an important role in crizotinib resistance in ALK fusion gene positive patients (this thesis).

4. Patients with EGFR mutant non-small cell lung cancer and concurrent EGFR amplification have worse prognosis when treated with EGFR-tyrosine kinase inhibitors compared to those without concurrent amplification (this thesis).

5. Amplification detection is important for lung cancer patients to identify possible underlying resistance mechanisms and may serve as a lead for clinicians to select optimal treatment (Clin Cancer Res. 2013 Apr 15;19(8):2240-7).

6. Cell-free DNA in plasma increases in cancer patients, after infections, trauma or surgery, while tumour-derived DNA is mostly undetectable in very early cancer stages and in post-surgery plasma (this thesis).

7. If you want to go fast, go alone. If you want to go far, go together (African Proverb). 8. Go for the messes, that’s where the action is (Steven Weinberg).

9. Nothing in life is to be feared, it is only to be understood. Now is the time to understand more, so that we may fear less (Nobel Laureate, Marie Curie).

10. Success is not final, failure is not fatal: it is the courage to continue that counts (Winston Churchill).

Jiacong Wei Groningen, Nov19th , 2019

Referenties

GERELATEERDE DOCUMENTEN

Management of acquired resistance to epidermal growth factor receptor kinase inhibitors in patients with advanced non‐small cell lung cancer. Acquired resistance to tkis in

In summary, this lung cancer specific all‐in‐one transcriptome‐based assay for simultaneous detection of mutations and fusion genes is highly sensitive and effective on both FFPE

The presence of gene amplifications was based on ratio of amplicon reads of a given gene relative to the reference amplicons in the sample or relative to

Using a different analysis strategy, performing separate pathway analysis for genes mutated in each individual patient we identified the metabolism pathway as the only pathway that

cfDNA: cell free DNA; ESCC: oesophageal squamous cell carcinoma; EC: oesophageal cancer; ddPCR: droplet digital PCR; ctDNA: circulating tumour DNA; NGS: next generation

Ultra‐sensitive detection of the pretreatment egfr t790m mutation in non‐small cell lung cancer patients with an egfr‐activating mutation using droplet digital pcr.

De FISH‐techniek wordt gebruikt voor amplificaties en specifieke chromosomale breuken, IHC wordt gebruikt om te bepalen of er eiwit overexpressie is, nanostring om fusiegenen

Harry Groen, not only for the opportunity that he offered me to initiate the lung cancer projects, but also for his consistent support and help during the past four years.. He